Abstract
Despite its high R&D intensity, the pharmaceutical industry is facing an increasingly dire situation. On average, only 1 out of 10,000 substances becomes a marketable product. And only 3 out of 10 drugs generate revenues that meet or exceed average R&D costs (see Grabowski, Vernon, DiMasi 2002).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
(2008). Innovation: Key to Success in the Pharmaceutical Industry. In: Leading Pharmaceutical Innovation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-77636-9_1
Download citation
DOI: https://doi.org/10.1007/978-3-540-77636-9_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-77635-2
Online ISBN: 978-3-540-77636-9
eBook Packages: Business and EconomicsBusiness and Management (R0)